Is JTP-74057 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use JTP-74057? Is JTP-74057 safe for nursing mother and child? Does JTP-74057 extracts into breast milk? Does JTP-74057 has any long term or short term side effects on infants? Can JTP-74057 influence milk supply or can JTP-74057 decrease milk supply in lactating mothers?
Answer by DrLact: About JTP-74057 usage in lactation
No information is available on the clinical use of JTP-74057 during breastfeeding. Because JTP-74057 is 97% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is 3.9 to 4.8 days and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during JTP-74057 therapy and for 4 months after the last dose.
Alternate Drugs
Vincristine(Dangerous)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Thioguanine(Dangerous)
Tamoxifen(Dangerous)
Nilotinib(Unsafe)
Mitoxantrone(Dangerous)
Mercaptopurine(Safe)
Trastuzumab(Unsafe)
Docetaxel(Dangerous)
Hydroxyurea(Low Risk)
Etoposide(Dangerous)
Dactinomycin(Dangerous)
Nivolumab(Unsafe)
Ipilimumab(Unsafe)
Doxorubicin(Dangerous)
Imatinib(Unsafe)
Cladribine(Dangerous)
Gemcitabine(Dangerous)
Cetuximab(Unsafe)
Cyclophosphamide(Dangerous)
Vinblastine(Dangerous)
Carboplatin(Dangerous)
Cisplatin(Unsafe)
Bleomycin(Dangerous)
Azelaic Acid(Safe)
Paclitaxel(Dangerous)
Busulfan(Dangerous)
Vinorelbine(Dangerous)
Fluorouracil(Dangerous)
Dacarbazine(Dangerous)
Letrozole(Dangerous)
Alemtuzumab(Low Risk)
Exemestane(Dangerous)
Dasatinib(Unsafe)
Rituximab(Low Risk)
Bevacizumab(Low Risk)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Gemcitabine(Dangerous)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Allopurinol(Safe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)
Pazopanib(Unsafe)
Erlotinib(Unsafe)
Nilotinib(Unsafe)